Use of nitric oxide inhalation in chronic obstructive pulmonary disease

Ashutosh, Kumar; Phadke, Kishor; Jackson, Jody Fragale; Steele, David
February 2000
Thorax;Feb2000, p109
Academic Journal
No abstract available.


Related Articles

  • The Effect of Nitric Oxide Inhalation on Pulmonary Gas Exchange and Exercise Capacity in Patients with Cystic Fibrosis. Stewart, Ian B.; Sheel, A. William; Frangiolas, Despina D.; Wilcox, Pearce G.; McKenzie, Don C. // Clinical Exercise Physiology;Feb2001, Vol. 3 Issue 1, p44 

    Attempts to improve aerobic exercise capacity by preventing oxyhemoglobin desaturation in patients with cystic fibrosis. Increase in exercise capacity in patients with severe congestive heart failure and chronic obstructive pulmonary disease following inhalation of nitric oxide; Evidence that...

  • Using FeNO in the diagnosis and management of asthma. Stonham, Carol // British Journal of Nursing;3/13/2014, Vol. 23 Issue 5, p266 

    The author reflects on the use of fractional exhaled nitric oxide (FeNO) in the diagnosis of asthma in children and adults. She mentions that some asthma symptoms are shared with other conditions such as bacterial lung infections and chronic obstructive pulmonary disease and talks about the use...

  • Deposition of inhaled fluticasone propionate in the respiratory tract of horses.  // Veterinary Record: Journal of the British Veterinary Association;9/18/2004, Vol. 155 Issue 12, p348 

    Reports on the use of inhaled anti-inflammatory and bronchodilatory drugs in the treatment of chronic obstructive pulmonary disease in horses.

  • Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Vonbank, K.; Ziesche, R.; Higenbottam, T.W.; Stiebellehner, L.; Petkov, V.; Schenk, P.; Germann, P.; Block, L.H. // Thorax;Apr2003, Vol. 58 Issue 4, p289 

    Background: Pulmonary hypertension is a frequent complication of severe chronic obstructive pulmonary disease (COPD) and a major cause of morbidity and mortality in this condition. Based on the improved survival of these patients due to long term oxygen therapy and the potent and selective...

  • Inhaled Steroids Increase Risk of TB in COPD Patients.  // Clinical Cardiology Alert;Jun2013 Clinical Briefs in Primary Care, p12 

    The article focuses on inhaled corticosteroids (ICS) were the use of these steroids leads to increase the risk of pulmonary tuberculosis (TB) in patients with chronic obstructive pulmonary disease (COPD).

  • INHALER THERAPY FOR OBSTRUCTIVE AIRWAY DISEASE.  // Journal of the Nepal Medical Association;Jul/Aug2004, Vol. 43 Issue 154, p1 

    Presents information on the effectiveness of inhaler therapy for chronic obstructive pulmonary disease (COPD). Varieties of inhalers for the treatment of COPD; Benefits of metered dose inhaler (MDI); Precautions in using MDI.

  • Inhaled corticosteroids worth it in patients with severe COPD.  // PharmacoEconomics & Outcomes News;5/8/2004, Issue 452, p9 

    Deals with the findings of a study regarding the use of inhaled corticosteroids among patients with chronic obstructive pulmonary disease. Cost effectiveness of inhaled corticosteroids; Mortality benefit of inhaled corticosteroids.

  • Recognition and Management of Pulmonary Hypertension. Wanstall, J.C.; Jeffery, T.K. // Drugs;Dec1998, Vol. 56 Issue 6, p989 

    Pulmonary hypertension (mean pulmonary arterial pressure >20mm Hg at rest or >30mm Hg during exercise) occurs (i) as primary pulmonary hypertension (no known underlying cause), (ii) as persistent pulmonary hypertension of the newborn or (iii) secondary to a variety of lung and cardiovascular...

  • Tiotropium for uncontrolled asthma.  // Neurology Alert;Dec2010 Supplement, p1 

    The article focuses on a study which investigated the therapeutic use of tiotropium, a long-acting anticholinergic inhaler, for patients with chronic obstructive pulmonary disease (COPD).

  • Ipratropium and cardiovascular events in COPD.  // Internal Medicine Alert;3/15/2010, Vol. 32 Issue 5, p39 

    The article discusses the risk on the use of metered-dose inhaler administration of ipratropium (IPR) among patients with chronic obstructive pulmonary disease (COPD).


Read the Article


Sign out of this library

Other Topics